{"center_node_id":"672","nodes":[{"id":"672","name":"BRCA1","type":"biolink:Gene","color":"#4A90D9","size":1.5,"is_expanded":true,"metadata":{"ncbi_gene_id":"672","hgnc_id":"HGNC:1100","symbol":"BRCA1","full_name":"BRCA1 DNA repair associated","chromosome":"17","aliases":["BROVCA1","FANCS","IRIS","PNCA4","RNF53"]}},{"id":"MONDO:0007254","name":"Breast Cancer","type":"biolink:DiseaseOrPhenotypicFeature","color":"#D0021B","size":1,"is_expanded":false,"metadata":{"mondo_id":"MONDO:0007254","umls_cui":"C0006142","icd10":"C50","prevalence":"Approximately 2.3 million new cases/year globally"}},{"id":"CHEMBL:4297","name":"Olaparib","type":"biolink:Drug","color":"#7ED321","size":1,"is_expanded":false,"metadata":{"chembl_id":"CHEMBL:4297","drugbank_id":"DB09074","mechanism":"PARP inhibitor","approval_status":"FDA approved (2014)","indication":"BRCA-mutated ovarian, breast, and prostate cancer"}},{"id":"675","name":"BRCA2","type":"biolink:Gene","color":"#4A90D9","size":1,"is_expanded":false,"metadata":{"ncbi_gene_id":"675","hgnc_id":"HGNC:1101","symbol":"BRCA2","full_name":"BRCA2 DNA repair associated","chromosome":"13","aliases":["BRCC2","BROVCA2","FACD","FAD","FAD1","FANCD","FANCD1","GLM3","PNCA2","XRCC11"]}},{"id":"R-HSA-5693538","name":"Homologous DNA Repair","type":"biolink:Pathway","color":"#9B59B6","size":1,"is_expanded":false,"metadata":{"reactome_id":"R-HSA-5693538","parent_pathway_id":"R-HSA-73894","parent_pathway_name":"DNA Repair","species":"Homo sapiens","reaction_count":42}},{"id":"5888","name":"RAD51","type":"biolink:Gene","color":"#4A90D9","size":1,"is_expanded":false,"metadata":{"ncbi_gene_id":"5888","hgnc_id":"HGNC:9817","symbol":"RAD51","full_name":"RAD51 recombinase","chromosome":"15","aliases":["BRCC5","MRMV2","RAD51A","RECA"]}}],"edges":[{"id":"672--MONDO:0007254","source":"672","target":"MONDO:0007254","predicate":"biolink:gene_associated_with_condition","label":"associated with","color":"#E74C3C","source_db":"disgenet","direction":"->","confidence_score":0.98,"provenance":"curated_db","evidence":[{"pmid":"7894493","snippet":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 was identified; the sequence contains an open reading frame of 7,224 nt and encodes a predicted protein of 1,863 amino acids.","pub_year":1994,"source":"PubMed"},{"pmid":"27433846","snippet":"BRCA1 somatic mutations occur in approximately 1.3% of breast cancers, with germline BRCA1 mutations conferring a 46-87% lifetime risk of breast cancer.","pub_year":2016,"source":"PubMed"}]},{"id":"CHEMBL:4297--672","source":"CHEMBL:4297","target":"672","predicate":"biolink:affects","label":"sensitizes to","color":"#27AE60","source_db":"chembl","direction":"->","confidence_score":0.95,"provenance":"curated_db","evidence":[{"pmid":"19553714","snippet":"Olaparib (AZD2281) induced synthetic lethality in BRCA-deficient cells at concentrations 1,000-fold lower than in BRCA-proficient cells, demonstrating selective cytotoxicity mediated by PARP inhibition.","pub_year":2009,"source":"PubMed"},{"pmid":"25673413","snippet":"In patients with germline BRCA1 or BRCA2 mutations and advanced cancer, olaparib showed antitumor activity based on the principle of synthetic lethality.","pub_year":2015,"source":"PubMed"}]},{"id":"672--675","source":"672","target":"675","predicate":"biolink:physically_interacts_with","label":"interacts with","color":"#F39C12","source_db":"reactome_ppi","direction":"<->","confidence_score":0.97,"provenance":"curated_db","evidence":[{"pmid":"9428769","snippet":"BRCA1 and BRCA2 colocalize at discrete nuclear foci after DNA damage and interact directly with RAD51, implicating both proteins in homologous recombination-mediated DNA repair.","pub_year":1998,"source":"PubMed"},{"pmid":"10373512","snippet":"The BRCA1 C-terminus (BRCT) domain interacts with BRCA2 via PALB2 bridging, forming a functional complex essential for HR repair of double-strand breaks.","pub_year":1999,"source":"PubMed"}]},{"id":"672--R-HSA-5693538","source":"672","target":"R-HSA-5693538","predicate":"biolink:participates_in","label":"participates in","color":"#8E44AD","source_db":"reactome","direction":"->","confidence_score":1,"provenance":"curated_db","evidence":[{"pmid":"10535901","snippet":"BRCA1 is required for homologous recombination-directed repair of DNA double-strand breaks. Cells lacking BRCA1 show a severe defect in HR and fail to form RAD51 foci after DNA damage.","pub_year":1999,"source":"PubMed"},{"pmid":"23913237","snippet":"BRCA1 promotes end resection of DNA double-strand breaks by facilitating CtIP phosphorylation, a critical initiating step in homologous recombination.","pub_year":2013,"source":"PubMed"}]},{"id":"672--5888","source":"672","target":"5888","predicate":"biolink:positively_regulates","label":"activates","color":"#F39C12","source_db":"fis_in_gene","direction":"->","confidence_score":0.92,"provenance":"curated_db","evidence":[{"pmid":"8944023","snippet":"BRCA1 colocalizes with RAD51 in discrete nuclear foci during S phase and after DNA damage, suggesting that BRCA1 regulates RAD51-mediated strand invasion during homologous recombination.","pub_year":1997,"source":"PubMed"},{"pmid":"15469989","snippet":"Loss of BRCA1 leads to impaired RAD51 recruitment to sites of DNA damage, resulting in defective homologous recombination and genomic instability.","pub_year":2004,"source":"PubMed"}]}]}
